Education
About Us
Working with TipRanks
Follow Us
Pavmed (PAVM)
:PAVM
Total Valuation
PAVmed has a market cap or net worth of $9.27M. The enterprise value is $34.62M.
Market Cap$9.27M
Enterprise Value$34.62M
Share Statistics
PAVmed has 21,610,516 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,610,516
Owned by Insiders5.78%
Owned by Institutions4.31%
Financial Efficiency
PAVmed’s return on equity (ROE) is -15.95 and return on invested capital (ROIC) is -179.19%.
Return on Equity (ROE)-15.95
Return on Assets (ROA)1.30
Return on Invested Capital (ROIC)-179.19%
Return on Capital Employed (ROCE)9.30
Revenue Per Employee76.79K
Profits Per Employee1.02M
Employee Count39
Asset Turnover0.10
Inventory Turnover22.70
Valuation Ratios
The current PE Ratio of PAVmed is 0.4. PAVmed’s PEG ratio is ―.
PE Ratio0.4
PS Ratio―
PB Ratio―
Price to Fair Value-2.43
Price to FCF―
Price to Operating Cash Flow-2.75
PEG Ratio―
Income Statement
In the last 12 months, PAVmed had revenue of 3.00M and earned 39.79M in profits. Earnings per share was 3.30.
Revenue3.00M
Gross Profit-3.04M
Operating Income-44.49M
Pretax Income28.43M
Net Income39.79M
EBITDA29.67M
Earnings Per Share (EPS)3.30
Cash Flow
In the last 12 months, operating cash flow was -2.77B and capital expenditures -24.00K, giving a free cash flow of -2.77B billion.
Operating Cash Flow-2.77B
Free Cash Flow-2.77B
Free Cash Flow per Share-128.08
Dividends & Yields
PAVmed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.31
52-Week Price Change-74.85%
50-Day Moving Average0.52
200-Day Moving Average0.66
Relative Strength Index (RSI)40.75
Average Volume (3m)301.82K
Important Dates
PAVmed upcoming earnings date is Nov 18, 2025, Before Open (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateNov 18, 2025
Ex-Dividend Date―
Financial Position
PAVmed as a current ratio of 0.06, with Debt / Equity ratio of 22824.22%
Current Ratio0.06
Quick Ratio0.05
Debt to Market Cap4.79
Net Debt to EBITDA1.03
Interest Coverage Ratio-988.60
Taxes
In the past 12 months, PAVmed has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
PAVmed EV to EBITDA ratio is 1.24, with an EV/FCF ratio of -1.09.
EV to Sales12.27
EV to EBITDA1.24
EV to Free Cash Flow-1.09
EV to Operating Cash Flow-1.10
Balance Sheet
PAVmed has $4.00B in cash and marketable securities with $9.31B in debt, giving a net cash position of $5.31B billion.
Cash & Marketable Securities$4.00B
Total Debt$9.31B
Net Cash$5.31B
Net Cash Per Share$245.53
Tangible Book Value Per Share-$0.73
Margins
Gross margin is -506.05%, with operating margin of -1485.38%, and net profit margin of 1328.58%.
Gross Margin-506.05%
Operating Margin-1485.38%
Pretax Margin949.15%
Net Profit Margin1328.58%
EBITDA Margin990.65%
EBIT Margin950.65%
Analyst Forecast
The average price target for PAVmed is $2.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.00
Price Target Upside365.12% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-73.36%
EPS Growth Forecast―